$0.23
-0.01 (-5.86%)
Open$0.25
Previous Close$0.24
Day High$0.25
Day Low$0.22
52W High$2.66
52W Low$0.10
Volume—
Avg Volume68.51M
Market Cap3.82M
P/E Ratio—
EPS$-2.06
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+10,916.7% upside
Current
$0.23
$0.23
Target
$25.14
$25.14
$18.28
$25.14 avg
$30.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 204.9K | 501.7K | 427.8K |
| Net Income | -245,012,378 | -539,806,952 | 33.9K |
| Profit Margin | -119,566.5% | -113,588.2% | 7.9% |
| EBITDA | -244,197,285 | -567,900,662 | 68.2K |
| Free Cash Flow | — | — | 23.2K |
| Rev Growth | -59.2% | -59.2% | +6.7% |
| Debt/Equity | 0.00 | 0.00 | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |